FOXM1 and plasma cell myeloma: Dampening glucose import using the HIV protease inhibitor ritonavir [48] and inhibiting PFK (phosphofructokinase) [49] or ENO (enolase) [50] have also been evaluated as experimental myeloma therapy, albeit with limited success and not in the context of upregulated FOXM1.